TY - JOUR
T1 - Global analysis of protein arginine methylation
AU - Zhang, Fangrong
AU - Kerbl-Knapp, Jakob
AU - Rodriguez Colman, Maria J
AU - Meinitzer, Andreas
AU - Macher, Therese
AU - Vujić, Nemanja
AU - Fasching, Sandra
AU - Jany-Luig, Evelyne
AU - Korbelius, Melanie
AU - Kuentzel, Katharina B
AU - Mack, Maximilian
AU - Akhmetshina, Alena
AU - Pirchheim, Anita
AU - Paar, Margret
AU - Rinner, Beate
AU - Hörl, Gerd
AU - Steyrer, Ernst
AU - Stelzl, Ulrich
AU - Burgering, Boudewijn
AU - Eisenberg, Tobias
AU - Pertschy, Brigitte
AU - Kratky, Dagmar
AU - Madl, Tobias
N1 - © 2021 The Authors.
PY - 2021/6/21
Y1 - 2021/6/21
N2 - Quantitative information about the levels and dynamics of post-translational modifications (PTMs) is critical for an understanding of cellular functions. Protein arginine methylation (ArgMet) is an important subclass of PTMs and is involved in a plethora of (patho)physiological processes. However, because of the lack of methods for global analysis of ArgMet, the link between ArgMet levels, dynamics, and (patho)physiology remains largely unknown. We utilized the high sensitivity and robustness of nuclear magnetic resonance (NMR) spectroscopy to develop a general method for the quantification of global protein ArgMet. Our NMR-based approach enables the detection of protein ArgMet in purified proteins, cells, organoids, and mouse tissues. We demonstrate that the process of ArgMet is a highly prevalent PTM and can be modulated by small-molecule inhibitors and metabolites and changes in cancer and during aging. Thus, our approach enables us to address a wide range of biological questions related to ArgMet in health and disease.
AB - Quantitative information about the levels and dynamics of post-translational modifications (PTMs) is critical for an understanding of cellular functions. Protein arginine methylation (ArgMet) is an important subclass of PTMs and is involved in a plethora of (patho)physiological processes. However, because of the lack of methods for global analysis of ArgMet, the link between ArgMet levels, dynamics, and (patho)physiology remains largely unknown. We utilized the high sensitivity and robustness of nuclear magnetic resonance (NMR) spectroscopy to develop a general method for the quantification of global protein ArgMet. Our NMR-based approach enables the detection of protein ArgMet in purified proteins, cells, organoids, and mouse tissues. We demonstrate that the process of ArgMet is a highly prevalent PTM and can be modulated by small-molecule inhibitors and metabolites and changes in cancer and during aging. Thus, our approach enables us to address a wide range of biological questions related to ArgMet in health and disease.
U2 - 10.1016/j.crmeth.2021.100016
DO - 10.1016/j.crmeth.2021.100016
M3 - Article
C2 - 35475236
SN - 2667-2375
VL - 1
SP - 1
EP - 15
JO - Cell reports methods
JF - Cell reports methods
IS - 2
M1 - 100016
ER -